Single Cell RNA-Sequencing of Pluripotent States Unlocks Modular Transcriptional Variation  by Kolodziejczyk, Aleksandra A. et al.
ResourceSingle Cell RNA-Sequencing of Pluripotent States
Unlocks Modular Transcriptional VariationGraphical AbstractHighlightsd mESCs grown in three different conditions show distinct
transcriptomes
d Global intercellular variation is at similar levels in all three
conditions
d 2i and a2i conditions maintain pluripotency with metabolic
variation
d Correlation analysis identifies additional pluripotency
network genesKolodziejczyk et al., 2015, Cell Stem Cell 17, 471–485
October 1, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.stem.2015.09.011Authors
Aleksandra A. Kolodziejczyk,
Jong Kyoung Kim,
Jason C.H. Tsang, ..., Pentao Liu,
John C. Marioni, Sarah A. Teichmann
Correspondence
marioni@ebi.ac.uk (J.C.M.),
st9@sanger.ac.uk (S.A.T.)
In Brief
Teichmann, Marioni, and colleagues
report full-transcript single cell RNA-
sequencing of mESCs cultured in three
different conditions: serum, 2i, and the
alternative ground state a2i. They find
that overall levels of intercellular
heterogeneity are comparable across the
three conditions, but different sets of
genes are variably expressed.
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Embryonic stem cell (ESC) culture conditions are
important for maintaining long-term self-renewal,
and they influence cellular pluripotency state. Here,
we report single cell RNA-sequencing of mESCs
cultured in three different conditions: serum, 2i, and
the alternative ground state a2i. We find that the
cellular transcriptomes of cells grown in these condi-
tions are distinct, with 2i being the most similar to
blastocyst cells and including a subpopulation
resembling the two-cell embryo state. Overall levels
of intercellular gene expression heterogeneity are
comparable across the three conditions. However,
thismasks variable expression of pluripotency genes
in serum cells and homogeneous expression in 2i
and a2i cells. Additionally, genes related to the cell
cycle are more variably expressed in the 2i and a2i
conditions. Mining of our dataset for correlations in
gene expression allowed us to identify additional
components of the pluripotency network, including
Ptma and Zfp640, illustrating its value as a resource
for future discovery.
INTRODUCTION
Mouse embryonic stem cells (mESCs) are derived ex vivo from
the inner cell mass of the developing blastocyst. They are
characterized by their capacity for in vitro self-renewal and the
preservation of developmental pluripotency to reconstitute em-
bryonic lineages (Bradley et al., 1984; Evans and Kaufman,
1981; Martin, 1981). Genetic studies have established the role
of Oct4 (Nichols et al., 1998), Sox2 (Avilion et al., 2003), Nanog
(Chambers et al., 2003; Mitsui et al., 2003) and Esrrb (Festuccia
et al., 2012) as the signature core factors in the pluripotency tran-
scriptional network of mESCs (Chen et al., 2008; Loh et al., 2006;
Marson et al., 2008).CeMaintenance of self-renewal in vitro is dependent on the inter-
play between extracellular cues and the pluripotency network.
This is conventionally achieved through combinatorial stimulation
of the JAK-STAT pathway and ID proteins by cytokine leukemia
inhibitory factor (LIF) and fetal calf serum (serum)/bone morpho-
genetic proteins (BMPs), respectively (Smith et al., 1988;Williams
et al., 1988; Ying et al., 2003). mESCs propagated in serum/LIF
conditions remain exposed to differentiation cues from autocrine
fibroblast growth factor 4 (FGF4) or LIF through the RAS-ERK
signaling pathway (Burdon et al., 1999; Kunath et al., 2007;
Niwa et al., 2009;Ying et al., 2008), althoughgenetic and chemical
inhibition of the FGF-ERK pathway alone is able to prevent differ-
entiation (Kunath et al., 2007). These findings led to the establish-
ment of the concept of ‘‘ground state pluripotency,’’ where differ-
entiation cues are shielded, and the pluripotency network is
intrinsically stable (Nichols and Smith, 2009; Ying et al., 2008).
With additional inhibition of glycogen synthase kinase 3
(GSK3), ground state mESCs can be robustly maintained
in vitro in the chemically defined 2i condition. Dual inhibition of
GSK3 and ERK promotes self-renewal by alleviating TCF3-medi-
ated repression, activating Esrrb expression, reducing degrada-
tion of KLF2 (Martello et al., 2012; Wray et al., 2011; Yeo et al.,
2014), and inducing Tfcp2l1 in concert with LIF (Ye et al., 2013).
Substituting ERK kinase inhibition with inhibition of members of
the SRC tyrosine kinase family can enable maintenance of an
alternative ground state, alternative 2i, or a2i (Li et al., 2011; Shi-
mizu et al., 2012). As SRC tyrosine kinase inhibition only partially
reduces phosphorylation of ERK kinase (Shimizu et al., 2012), its
effect on differentiation is not limited to convergent upstream in-
hibition of the FGF-ERK pathway. It has instead been suggested
to block the epithelial-mesenchymal transition downstream of
both the calcineurin-NFAT and the FGF-ERK pathways (Li
et al., 2011) and stop differentiation bymechanical stress through
an ERK-independentmechanism (Shimizu et al., 2012). Thus, the
self-renewing pluripotent state of mESCs can be achieved
through manipulation of key signaling pathways in vitro.
Despite sharing a common origin and defining properties,
mESCs propagated under different culture conditions also differ
(Ficz et al., 2013; Marks et al., 2012). For instance, serum/LIF-
maintained mESCs are morphologically heterogeneous andll Stem Cell 17, 471–485, October 1, 2015 ª2015 The Authors 471
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Figure 1. Experimental Scheme of Hybrid
mESCs in Three Culture Conditions
Schematic of experimental setup and cell culture
conditions used in our study.show transcriptional fluctuation of certain pluripotency factors
such as Nanog (Chambers et al., 2007; Kalmar et al., 2009),
Dppa3 (Hayashi et al., 2008), and Rex1 (Zfp42) (Toyooka et al.,
2008), unlike mESCs maintained in 2i conditions. These fluctua-
tions have been proposed to represent a dynamic equilibrium
between self-renewing and differentiation-poised states and
thus be instrumental in regulating exit from pluripotency (Chang
et al., 2008). However, others speculate that they arise through
the use of fluorescent reporter systems and therefore are of un-
clear biological relevance (Chang et al., 2008; Faddah et al.,
2013; Reynolds et al., 2012). The presence of transcriptionally
heterogeneous subpopulations, prevalent bivalent chromatin
domains, increased methylation content, and reduced RNA po-
lymerase pausing compared to 2i mESCs has led to the notion
that serum-maintained mESCs exist in a metastable pluripotent
state (Marks et al., 2012), implying higher transcriptional cell-to-
cell variation than the 2i state. Recently, a rare population of
mESCs expressing markers of the two-cell stage of embryonic
development was described (Macfarlan et al., 2012). These so-
called 2C-like cells express the MERVL endogenous retrovirus
and chimeric transcripts that arise via retroviral insertion in
different places in the genome, and they are uniquely capable
of differentiating into extraembryonic tissues. Our molecular un-
derstanding of the divergent pluripotent states, however, re-
mains quite limited.
Single cell RNA-sequencing technology is increasingly used
to deconstruct heterogeneous populations, lineage trajectories,
and determinants of cell fate, questions that are central to the
stem cell field (Etzrodt et al., 2014). Recently, Kumar et al.
(2014) reported the single-cell transcriptome of serum/LIF-main-
tained mESCs and global transcriptome changes resulting from
a range of chemical and genetic perturbations. Here, we per-
formed single cell RNA-sequencing of mESCs cultured in
serum/LIF, 2i/LIF, and the alternative ground state, a2i/LIF.
This approach allowed us to compare the subpopulation struc-
tures and provide a deep characterization of cell-to-cell variation
in gene expression levels across these three pluripotent states.472 Cell Stem Cell 17, 471–485, October 1, 2015 ª2015 The AuthorsRESULTS
To examine features of gene expression
heterogeneity across pluripotent states,
we cultured an F1 hybrid (C57BL/6Ncr
male x 129S6/SvEvTac female) mESC
cell line (George et al., 2007) in three
different conditions: (1) three replicates
of serum + LIF, (2) four replicates of 2i +
LIF, and (3) two replicates of a2i + LIF,
which we will refer to as serum (serum1,
serum2, and serum3), 2i (2i1, 2i2, 2i3,
and 2i4) and a2i (a2i1 and a2i2) hence-
forth (Figure 1). In total, we collected
704 single-cell transcriptomes acrossthese three conditions by using the Fluidigm C1 system and
applying the SMARTer Kit to obtain cDNA and the Nextera XT
Kit for Illumina library preparation.
After quality control analysis on each individual cell (Figures
S1A–S1H), 250 serum cells, 295 2i cells, and 159 a2i cells re-
mained. On average, we sequenced over 9 million reads per
cell. Over 80% of reads mapped to the Mus musculus genome
(GRCm38) and over 60% to exons (mapping overview in Figures
S1G and S1H). We also performed standard bulk RNA-
sequencing for each condition. As in previous studies, when
we averaged gene expression levels across the single cells pro-
filed in each condition, we observed that the mean expression
levels recapitulated the bulk gene expression levels with a
Spearman rank correlation coefficient of around 0.9 (Figures
S1D and S1E).
Transcriptome-wide Cell-to-Cell Variation Is Similar
across the Three Culture Conditions
An advantage of the single-cell approach is that we can study the
distribution of expression levels across the population, thereby
capturing cell-to-cell variability in gene expression (Figure 2A).
To compare global levels of gene expression heterogeneity
between the three different culture conditions, we used the coef-
ficient of variation (CV) of normalized read counts (Figure S2).
However, the CV of a gene depends strongly on its mean expres-
sion level and length, making it difficult to interpret differences
between conditions. To account for the confounding factor of
expression level, we therefore developed a measure of cell-to-
cell variation by calculating the distance between the squared
CV of each gene and a running median (Figures S2E and S2F).
This is derived from the scatterplot of the mean normalized
read counts versus the squared CV values, as in (Newman
et al., 2006). We refer to this expression-level normalized mea-
sure of gene expression heterogeneity as distance to themedian
(DM) (refer toSupplemental Experimental Procedures for details).
Given the heterogeneous morphology of mESCs cultured in
serum (Marks et al., 2012; Toyooka et al., 2008), as well as the
heterogeneous expression of pluripotency factors (Canham
et al., 2010; Hayashi et al., 2008; Kalmar et al., 2009; Singh
et al., 2007), it was surprising that transcriptome-wide DM values
are not significantly different across the three culture conditions
(p = 0.625 by the Freidman rank sum test) (Figures S2B–S2D).
This prompted us to askwhether the levels of heterogeneity for
genes belonging to individual functional categories are also
consistent between conditions. We first performed gene set
enrichment analysis for each culture condition to test whether
genes belonging to Gene Ontology (GO) terms are enriched
among those genes with extreme DM values. We observed
that genes involved in translation, ribosome, RNA binding, struc-
tural molecule activity, and mRNA processing have a lower level
of gene expression heterogeneity for all conditions (Figure S3D).
In contrast, genes involved in plasmamembrane, metal ion bind-
ing, lysosome, and integral component of membrane exhibit
higher variation than expected by chance in all three conditions
(p < 104). To gainmore insight into how gene expression hetero-
geneity for functional categories differs between culture condi-
tions, we compared the DM values of genes in pairs of culture
conditions for each GO term (excluding 2i replicates containing
2C-like cells; for discussion of 2C-like cells, see below) (Figures
2B–2D, Figures S3A and S3B). We found that 712 GO terms (out
of a total of 19,107 terms) exhibit a significant difference in levels
of gene expression heterogeneity in at least one pairwise com-
parison (p < 0.01). For example, the expression of genes involved
in ‘‘organ development’’ (p = 3.3 3 104) and ‘‘cell adhesion’’
(p = 4.8 3 104) is more heterogeneous in serum than in the
inhibitory conditions (2i and a2i): these terms contain many plu-
ripotency factors.
In contrast, genes involved in ‘‘cell cycle’’ (p = 5.43 103) and
‘‘nuclear division’’ (p = 5.9 3 106) have higher levels of gene
expression heterogeneity in 2i compared to serum (Figures
2B–2D, Figures S3A and S3B). When we included 2i replicates
containing 2C-like cells, we observed a similar trend (Fig-
ure S3C). When clustering cells based on cell-cycle genes
only, we found that 2i cells separate into two groups: one with
high expression of G2 and M genes and a second with lower
expression of these genes (Figures 2E and 2F). Cells in serum
and 2i also show different doubling kinetics with a rapid initial
growth rate in 2i (24 hr). At the time of harvest, however (48 hr
after plating), the doubling time of cells in 2i is 25 hr and in serum
it is 11 hr, indicating that cells grown in 2i cycle more slowly,
probably due to a longer G1 phase (refer to Supplemental Exper-
imental Procedures).
As an independent validation, we performed the same analysis
using data published previously (Gru¨n et al., 2014). Consistent
with our observations, global levels of gene expression
heterogeneity between cells grown in 2i and in serum were
comparable, while GO categories for development and dif-
ferentiation were more heterogeneous in serum than in 2i, and
cell-cycle genes were more heterogeneous in 2i than in serum
(Figures S3E–S3G, Supplemental Experimental Procedures,
Table S2).
Three Subpopulations Can Be Delineated in
Serum-Grown mESCs
Genes with heterogeneous expression, especially those with
clear bimodal expression (Figure 2A), may indicate the existenceCeof underlying subpopulations. Indeed, hierarchical clustering of
subsets of known pluripotency genes and differentiationmarkers
reveals that serum-grown cells split into three distinct groups
(Figure 3A). Similar to others, we found heterogeneous expres-
sion of Nanog (Faddah et al., 2013; Kalmar et al., 2009;
MacArthur et al., 2012; Singh et al., 2007), Esrrb (van den Berg
et al., 2008), and Zfp42 (Toyooka et al., 2008) in serum, as well
as heterogeneous expression of Nr0b1 and Utf1.
One subpopulation consists of 39 cells (15%) that express
higher levels of markers of differentiation, for example Fos or
Hes1, and high levels of cytoskeletal genes such as keratins
(Krt8 and Krt18), actins (Acta1 and Acta2), and annexins
(Anxa1, Anxa2, and Anxa3). At the same time, these 39 cells
have low levels or no expression of transcription factors involved
in the maintenance of pluripotency (e.g.,Nanog, Sox2, andOct4)
(Figures 3B and 3C), suggesting that these cells have exited plu-
ripotency and committed to differentiation. A second group con-
sists of 42 cells (17%) with somewhat lower expression levels of
some pluripotency genes, such as Dppa3 and Nanog, and some
expression of differentiation genes, yet high expression of Oct4
and Sox2. These cells may correspond to a previously described
‘‘differentiation permissive’’ set (Chambers et al., 2007; Islam
et al., 2014; Kalmar et al., 2009). The largest group, which con-
sists of 169 cells (68%), expresses the highest levels of pluripo-
tency factors and exhibits very low expression of keratins or
actins (Figures 3B and 3C).
We observe that the 39-cell and 42-cell populations, which
have begun to move forward on the differentiation pathway,
have heterogeneous expression of cell-cycle genes (Figure 3D).
A shift in the distribution of the expression of G2/M genes, such
as Cks2 or Cdc20, toward lower levels suggests that there are
relatively more G1/S cells in these two groups as well. We in-
ferred that more differentiated cells have a relatively longer G1
phase, as we sample more cells in G1 from this subpopulation
relative to more pluripotent cells. This indicates that the 39-cell
and 42-cell subsets that we identified proliferate more slowly
than Nanog-high ground state pluripotent cells (Figure 3D).
Moreover, we performed principal component analysis (PCA) of
our data together with cells from an mESC-to-NPC (neural pro-
genitor cell) differentiation time course (Bibel et al., 2007). We
observed that cells belonging to the differentiating subpopulation
overlapwithcells that aredifferentiating towardNPCs (FigureS4).
This strongly supports our earlier hypothesis that these cells are
indeed progressing down a differentiation pathway (Figure 3A).
Ground State mESCs Cultured in Different Media Have
Non-Overlapping Transcriptomes
Kalmar et al. (2009) suggested that mESCs grown in 2i are
similar, or potentially identical, to the Nanog-high mESC sub-
population cultured in serum. To investigate whether ground
state mESCs in serum (i.e. the cells we identified as most plurip-
otent within serum-only media) have a similar transcriptome to 2i
or a2i mESCs, we clustered each population based on their
global expression profiles. PCA (Figure 4A) demonstrates three
separate clusters, revealing that ground state mESCs grown un-
der different culture conditions in fact have distinct transcrip-
tome identities. This is consistent with observations comparing
bulk RNA-sequencing of Rex1-high (Zfp42-high) cells in serum
and cells in 2i (Marks et al., 2012).ll Stem Cell 17, 471–485, October 1, 2015 ª2015 The Authors 473
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The Spearman correlation coefficient of mean gene expres-
sion levels between cells grown in the two inhibitory conditions
is 0.95; between 2i and serum, it’s 0.88; and between a2i and
serum, it’s 0.91. While these results suggest that 2i and a2i cells
are more similar to each other than to serum-cultured cells, dif-
ferences do exist between the two populations. Differences be-
tween 2i and a2i arise from the use of different inhibitors (Shimizu
et al., 2012). Inhibition of Mek1/2 results in dephosphorylation of
Erk1/2, while inhibition of Src does not have this effect, as we
show by western blotting (Figure S1K).
To examine what differences in gene expression between the
culture conditions explain the separation into distinct clusters,
we performed GO enrichment analysis. We found that genes
involved in development and differentiation, MAPK signaling,
and basicmetabolism are responsible for the separation (Figures
4B and 4C). To identify specific genes, we used DESeq, where
each cell was considered a replicate of its culture condition, to
test for significant differences in expression (Anders and Huber,
2010) as described in the Supplemental Experimental Proce-
dures. There is a substantial amount of technical noise in sin-
gle-cell data, so we considered only genes that are expressed
on average above 50 normalized counts, as the technical bias
is most pronounced for lowly expressed genes (Brennecke
et al., 2013). This results in 4,587 differentially expressed genes
between serum-grown cells and 2i-grown cells, 3,056 between
serum and alternative 2i, and 2,061 genes between the two
inhibitory conditions (the list of DE genes is available at http://
www.ebi.ac.uk/teichmann-srv/espresso; Figure S5).
The two most enriched GO categories in genes differentially
expressed between serum and 2i are in utero embryonic devel-
opment (GO:0001701) and positive regulation of transcription
from RNA polymerase II promoter (GO:0045944) (Table S1).
Many of the transcription factors in the latter are key genes
involved in pluripotency, such as Nanog, Oct4, Klf4, and Sox2.
The differences between the two inhibitory conditions are
smaller, and key terms are related to cell cycle, metabolism,
and translation. Importantly, Oct4, Sox2, and Klf4 are not differ-
entially expressed between 2i and a2i. Additionally, while Nanog
is significantly differentially expressed, the expression level
difference between 2i and a2i is smaller than between 2i and
serum (log fold change = 0.71, adj p < 106 and log fold
change = 2.4, adj p < 1098, respectively). We observed the
same pattern of differential gene expression in the bulk RNA-
sequencing experiments (Table S1).
We hypothesized that differences between 2i and a2i, which
are related to cell cycle and metabolism, may originate fromFigure 2. Global Cell-to-Cell Variation in Gene Expression
(A) Gene expression distributions of genes, which are noisier in 2i than serum, that
of gene expression were smoothed using the kernel density estimation functio
expression profiles between culture conditions (two-sided KS test p value for 2i an
such as Ccnb1, are more heterogeneous in 2i (p = 7 3 104 by two-sided KS tes
heterogeneous in serum (p < 1015 by two-sided KS test between 2i and serum
(B) Comparison of the levels of gene expression and noise for gene ontology (GO
cells). The logarithm (log10) of p values from two-sided paired t tests applied tome
category and plotted against each other by multiplying the sign of the t statistic.
(C and D) Example of a GO category (GO:0000280, nuclear division) that is noisi
(E) Heatmaps showing the expression of cell-cycle-related genes in serum and 2i,
between individual cells in serum.
(F) Gene expression profiles for key cell-cycle genes in all conditions show more
Cedifferent proportions of G1/S to G2/M phase cells in each condi-
tion. Indeed, using pre-defined cell cycle marker genes, we
found that roughly 60% of cells in 2i are in G2/M and only 35%
of cells are in G2/M in a2i. We therefore split the cells in each cul-
ture condition into G2/M and G1/S subgroups and compared
G2/M cells from 2i with G2/M cells from a2i, and we did similarly
for the G1/S subgroups. Subsequently, we considered the inter-
section of genes that were differentially expressed in each com-
parison and performed GO enrichment and KEGG pathway
enrichment analyses. Overall, there are 97 genes with higher
expression in 2i and 449 genes with higher expression in a2i.
The genes that are upregulated in a2i are involved in RNA
processing and transport, translation, and basic metabolism
(Figure S6A).
The fact that, even after accounting for cell cycle, differentially
expressed genes relate to basic cellular processes led us to
explore whether cells cultured in a2i have more mRNA than cells
cultured in 2i. To do this we exploited an external spike in mole-
cules that we added to one batch of the cells (2i2, a2i2, and
serum 3). The same number of molecules was added to each
cell lysate, meaning that the ratio of all reads mapped to the
spike ins to all reads mapped to exons can be considered as a
proxy for cellular mRNA content (Ding et al., 2015; Stegle
et al., 2015). Confirming the reliability of our approach, when
we divided 2i and a2i cells into G1/S and G2/M subpopulations
and compared their mRNA content, we found that cells in
G2/M have significantly more mRNA than cells in G1/S
(Figure S6B). Importantly, we observed that cells in 2i contain
significantly fewer mRNA molecules than cells in serum and a2i
(Wilcoxon test p < 1015 for both comparisons), which supports
the differential expression of genes involved in basic cellular
processes.
mESC Transcriptomes Are Similar, but Not Identical, to
Those of Blastocyst Cells
It has been suggested that the pluripotent state of 2i cells resem-
bles the cell state of early epiblast cells in the blastocyst (Boro-
viak et al., 2014; Nichols and Smith, 2009). The recent availability
of single cell RNA-sequencing data from different stages of
mouse embryonic development allowed us to assess the rela-
tionship of in vitro ESCs and in vivo blastomeres (Deng et al.,
2014). Our cells were prepared with a very similar protocol, so
we used PCA to overlay our data with the published embryonic
time course. As expected, mESCs are most similar to the blasto-
cyst stage cells from which they were derived, but they do not
overlap (Figures 4D and 4E). The difference between in vivohave similar noise profiles in serum (red), 2i (blue), and a2i (yellow). Distributions
n in R with default parameters. Tcerg1 does not have significantly different
d a2i comparison is 0.82, and for 2i and serum, 0.16). By contrast, other genes,
t between 2i and serum), while some, such as Nanog, Klf4, or Nr0b1, are more
for genes shown).
) categories between serum and 2i (excluding 2i replicates containing 2C-like
an normalized read counts (x axis) and DMs (y axis) was computed for eachGO
er in 2i (C) and is similarly expressed between the two conditions (D).
with a distinct separation into G1/S versus G2/M cells in 2i, with less distinction
heterogeneity in 2i.
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blastocyst cells and cells cultured in 2i may originate from differ-
ences in the mouse strains and/or sequencing protocols, as well
as transcriptome changes resulting from in vitro adaptation.
mESCs grown in the inhibitory conditions are the most similar
to the in vivo blastocyst cells, while serum cultured cells are
somewhat more distant (Figures 4D and 4E), which has also
been shown previously using cell ensembles (Boroviak et al.,
2014).
The dispersion of mESCs in each culture condition is smaller
than the dispersion between cells in the blastocyst. This may
be explained by noting that mESCs are derived by clonal expan-
sion and cultured in homogeneous conditions relative to the
complexity of cellular niches within the embryo. Moreover, blas-
tocyst cells were obtained from several embryos, thus adding an
additional factor that may increase heterogeneity. We quantified
global transcriptome noise using the DM measure to compare
the heterogeneity of blastocyst cells from three stages (early,
mid, and late) versus mESCs cultured in 2i. In all comparisons,
blastocyst cells are significantly more heterogeneous than the
cultured cells (p < 104 by Wilcoxon signed rank test).
Identification and Characterization of 2C-like Cells in 2i
Medium
To find 2C-like cells in our samples, we examined the expression
profile of genes shown previously to have at least 10-fold enrich-
ment in 2C-like marker genes relative to the remaining mESCs
(Macfarlan et al., 2012). Hierarchical clustering suggested the
presence of ten 2C-like cells in 2i, and none in the a2i or serum
culture conditions (2C-like cells may still be present in a2i and
serum, but at a very low rate) (Figure 5A).
Globally, the transcriptomes of 2C cells are altered, and only
about 50% of reads on average map to exons, compared to
60% in the remaining population in 2i (Figure 5B). Additionally,
we observed substantial MERVL expression in 2C-like cells
and no expression in the remaining cells (Figure 5C). Subse-
quently, we calculated the mean expression level of genes iden-
tified by Macfarlan et al. (2012) as differentially expressed in 2C-
like cells and observed a similar pattern in our data (Figure 5D).
Interestingly, we also observe that 2C-like cells have more upre-
gulated genes than downregulated genes (Figure 5E).
It should be noted that globally, 2C-like cells are more similar
to 2i cells and blastocyst cells than to cells from the two-cell
stage of the in vivo embryo. 2C-like cells cluster together with
2i cells (Figure 5A), and there are only 294 differentially ex-
pressed genes between 2C-like cells and the remaining 2i cells
(examples in Figure 5F). In comparison, we find 1,700 genes be-
tween 2C-like cells and blastocyst and 1,779 between 2C-like
cells and two-cell stage cells (for differential expression results
see http://www.ebi.ac.uk/teichmann-srv/espresso). In terms ofFigure 3. Population Structure in Serum, 2i, and a2i Cells
(A) Clustering of cells in three culture conditions using a panel of pluripotency fa
calculated using Spearman correlation. Below the heatmap we show a model o
express differentiation markers (red), cells that are primed for differentiation while
pluripotency (green).
(B andC) Gene expression distributions of genes that become downregulated (B) a
normalized counts. Oct4 expression is similar in cells closer to the ground state of
much lower in cells we defined as moving toward differentiation (red).
(D) Gene expression distributions of cell-cycle genes.
Ceexpression of Nanog, Oct4, Sox2, and Myc, 2C-like cells are
also similar to 2i cells in comparison to the two-cell and blasto-
cyst stages of the embryo (Figure 5G).
Transcriptional Regulatory Interactions in mESCs
Revealed by Gene-to-Gene Correlations
Above, we mined our high-throughput single cell RNA-
sequencing data from the perspective of comparing in vitro
and in vivo pluripotent cell populations.We next examined its po-
tential as a rich resource for analyzing correlations in gene
expression across culture conditions as a strategy to identify
candidate regulators of pluripotency. This allows us to develop
hypotheses about the transcriptional regulatory networks that
regulate pluripotency in mESCs, which is known to be highly in-
terconnected and complex (Boyer et al., 2005; Kim et al., 2008;
Loh et al., 2006).
We found that in serum-cultured mESCs, Nanog expression
correlates positively with transcription factors (Esrrb, Klf4,
Oct4/Pou5f1, Sox2, and Zfp42), genes involved in DNA
methylation (Dnmt3a, Tet1, and Tet2), and other genes such as
nuclear receptor Nr0b1 and histone lysine acetyltransferase
Kat6b. Nanog is negatively correlated with differentiation regula-
tors including transcription factors Gata3 and Klf7 (Figure 6).
These findings concur with known interactions in the pluripo-
tency regulatory network, where Nanog regulates Esrrb (Boyer
et al., 2005), Zfp42 (Shi et al., 2006), and Klf4 (Zhang et al.,
2010). Beyond confirming known interactions, we identified cor-
relations between characterized pluripotency genes and candi-
date components of the pluripotency transcriptional regulatory
network.
Of the candidate genes we selected seven genes for valida-
tion: Ptma, Zfp640, Zfp710, Dpy30, Set, Etv5, and Kat6b. First,
using ChIP-seq and ChIP-ChIP data from the ESCAPE data-
base, we found that the promoters of six of the candidate genes
are bound by core pluripotency genes (Figure 7A) (Xu et al.,
2013). To provide insight into the functional role of these genes,
we downregulated their expression using a CRISPR/dCas9
repressor that targeted their promoters (Figure 7B) (Gao et al.,
2014) before examining changes in their transcriptomes using
bulk RNA-sequencing.
We narrowed down our analysis to four cases that showed sig-
nificant repression of the targeted gene (Figure 7C) and per-
formed differential expression analysis between samples and
control gRNA using DESeq. After correcting for multiple hypoth-
esis testing, we found significantly differentially expressed genes
in two cases: Ptma and Zfp640 (Figure 7E). In the samples with
repressed Ptma, we observed a decrease in the expression of
pluripotency genes and an increase in the expression of genes
associated with differentiation (Figure 7D, where pluripotencyctors and differentiation markers. Correlations between cells and genes were
f the subpopulations of cells grown in serum. The schematic shows cells that
remaining pluripotent (orange), and cells that are closest to the ground state of
nd upregulated (C) upon differentiation. Expression is shown as log2 size factor
pluripotency (green) and cells that are primed for differentiation (yellow), and it is
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Figure 4. Clustering of mESCs Grown in Serum, 2i, and a2i Media
(A) All cells (n = 704) grown in the three different culture conditions are projected onto the first two principal components. All genes with mean normalized read
counts larger than ten were considered and principal component analysis (PCA) was performed.
(B) Distribution of genes contributing to PC1.
(C) GO enrichment analysis of genes most strongly contributing to PC1 separation.
(legend continued on next page)
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and differentiation genes are as in Figure 3). Zfp710 and Zfp640
show a similar but milder phenotype, while for Dpy30 there is no
clear change in the expression of pluripotency genes (Fig-
ure S6C). The lack of effect of Dpy30 downregulation on plurip-
otency gene expression is consistent with a previous report
(Jiang et al., 2011). Overall, these results suggest that Ptma
and Zfp640, and potentially also Zfp710, are candidate genes
involved in regulating the exit from pluripotency.
DISCUSSION
Here, using single cell RNA-sequencing, we quantified features
of cell-to-cell gene expression heterogeneity in mESCs cultured
in three different culture conditions. Previous studies had
assumed, based on expression of key pluripotency genes, that
cells cultured in mESCs are more heterogeneous. Surprisingly,
we found that on a global level, cells grown in 2i, a2i, and serum
are indistinguishable in terms of transcriptome-wide heteroge-
neity. Gene expression heterogeneity in specific subsets of
genes instead uniquely defines each pluripotent state.
Our results show that mESCs form transcriptomically distinct
cell populations depending upon the growth medium (serum,
2i, or a2i), with cells cultured in 2i and a2i being the most similar
to each other. When compared to single cells from different
stages of mouse embryonic development, all three sets of
cultured mESCs are closest to cells from the blastocyst stage,
which is the stage from which the cells were extracted originally.
The 2i and a2i cultured ESCs seemmore similar to the blastocyst
cells than serum cells. Additionally, we observed that 2C-like
cells are globally more similar to blastocysts than to two-cell
stage embryonic cells.
Recently, single cell RNA-sequencing of serum-grown
mESCs (Islam et al., 2014) showed a subpopulation with low
Nanog expression. Additionally, a qPCR study using a panel
of 48 pluripotency markers showed that cells cultured in
serum exist in two distinct states, with a small number of cells
appearing to reside in an intermediate state (Papatsenko et al.,
2015). We extended this analysis to identify two smaller sub-
sets of differentiated-committed and intermediate mESCs and
a larger self-renewing population. The first shows clear down-
regulation of Oct4 and Sox2 and a slower cell cycle, suggestive
of irreversible commitment. In contrast, the intermediate
population with higher expression of Oct4 and Sox2 may retain
the capacity to reacquire pluripotency. Importantly, we also
found that the mESC subset that expresses high levels of
Nanog in serum is not similar to ‘‘ground state pluripotency’’
2i cells.
a2i medium has been described as an alternative ground state
that can be achieved through the use of a different inhibitor (Shi-
mizu et al., 2012). As expected, a2i is not identical to 2i, but we
believe that it is rightfully called an alternative ground state: on
the transcriptome level, especially with respect to pluripotency
genes, a2i cells are similar to 2i and in vivo blastocyst cells. In(D) PCA loading plot of the Spearman’s rank correlation coefficients frommESCs
the mapping of mESCs in mouse development stages. The cells are visualized
correlation matrix between cells, where we used the same expression cutoff as
(E) PCA of Spearman’s rank correlation matrix between cells from three conditio
Ce2i and a2i media, there are no subpopulations of differentiating
mESCs; hence, pluripotency genes are expressed more homo-
geneously. Despite these similarities, it is intriguing to note that
a2i cells have a cellular RNA content similar to serum-cultured
cells, while 2i cells contain about half as much RNA on average,
independent of cell-cycle stage. It should be noted that Myc is
differentially upregulated in a2i cells compared to 2i cells. As
Myc has recently been shown to behave as a transcriptional
amplifier of active genes (Lin et al., 2012; Nie et al., 2012), it pro-
vides a potential mechanistic basis for the elevated mRNA con-
tent in a2i cells.
We observed a relationship between variability in the expres-
sion levels of cell-cycle genes and the length of the cell cycle.
mESCs cultured in serum have the lowest level of gene expres-
sion heterogeneity and mESCs in 2i have the highest, which cor-
relates negatively with doubling times in culture (doubling times
were quickest for serum and slowest for 2i). For dividing popula-
tions where the cell cycle is very slow, such as HSCs, it is
possible to assign cells to one of four cell-cycle stages, but
this is more challenging for cells that cycle more quickly (Tsang
et al., 2015).
In 2i, but not in a2i, we observed a subpopulation of 2C-like
cells that also contribute to heterogeneity within the 2i popula-
tion. As they are similar to the majority of 2i cells and rare, their
contribution to the global heterogeneity of 2i cells is much
smaller than the three distinct subpopulations in serum. It is
worth noting that our results show that 2C-like cells are not
particularly similar to cells at the two-cell stage of the embryo,
as was suggested previously.
Finally, our data and methodology allowed us to find new
genes involved in the pluripotency network, which we validated
using CRISPR repression. We found that downregulating
Zfp640, Zfp710, and Ptma affected the expression of both plu-
ripotency and differentiation genes. Ptma repression resulted
in the strongest deviation from control samples, and we infer
that these cells deviate from pluripotency toward a differentiated
state. Interestingly, Ptma is a well-known gene encoding prothy-
mosin alpha, which upon cleavage becomes thymosin alpha, a
peptide that has been well studied in the context of immunity
and that is used in the treatment of Hepatitis B and C and cancer
(Ciancio and Rizzetto, 2010; Garaci et al., 2012; Ioannou et al.,
2012). The mode of action of Ptma has been studied in cancer
and immune cells, and it has been shown to play a role in prolif-
eration through mechanisms involving chromatin remodeling
and interaction with numerous pathways associated with plurip-
otency maintenance such as the JAK-STAT pathway, the PI3K-
Akt pathway, and the NF-kB pathway (George and Brown, 2010;
Guo et al., 2015; Yang et al., 2004).
In summary, single-cell transcriptomics has allowed us to gain
deep insights into the subpopulation structure within mESC cul-
tures. These results emphasize the power of transcriptomics
at single-cell resolution for understanding multiple biological
processes.and single cells of mouse preimplantation embryos (Deng et al., 2014) showing
by loadings of the first three principal components of the Spearman’s rank
that employed by Deng et al.
ns and blastocyst. The first three components are shown.
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Figure 5. 2C-like Population
(A) Clustering of cells grown in 2i using markers of the 2C-like state (Macfarlan et al., 2012). Correlations were calculated using Spearman correlation. The
dendrogram divides cells into two groups, one of which contains ten cells expressing 2C-markers.
(B) Boxplot showing percentage of reads mapping to the exons in both subpopulations of cells in 2i. p was calculated using a Wilcoxon test.
(C) Boxplot showing RPM (reads per million) mapping to the MERVL retrovirus in both subpopulations of cells in 2i. p was calculated using a Wilcoxon test.
(D) Mean expression of genes reported to be at least 2-fold upregulated or downregulated in 2C-like cells (Macfarlan et al., 2012) in cells that we identified as
2C-like cells and in the remaining 2i cells.
(legend continued on next page)
480 Cell Stem Cell 17, 471–485, October 1, 2015 ª2015 The Authors
Figure 6. Spearman Correlation Matrix of Transcription Factors and Key Pluripotency Genes
The heatmap shows the correlation coefficients between a set of transcription factors and other key genes involved in pluripotency. Above are examples of genes
with expression patterns that correlate positively and negatively (from the left: Zfp42 and Creb3, Zfp42 and Nanog, Tet1 and Tet2, Tet1 and Jarid2).EXPERIMENTAL PROCEDURES
Cell Culture of mESCs
The G4 (C57BL/6Ncr x 129S6/SvEvTac) mouse hybrid (George et al.,
2007) ESCs were obtained from Mount Sinai Hospital and were
maintained on STO feeders in serum-containing media at 5% CO2 and
37C. They were sub-cloned, and a line with normal karyotype was
selected for further analysis. The cells were split onto gelatinized plates
(10 cm, Corning) and expanded in serum-containing media or chemically
defined media (standard 2i or alternative 2i) for at least three passages.(E) Barplot showing the number of significantly (DESeq, adjusted p < 0.05) upreg
(F) Gene expression distributions of genes that become upregulated or downregul
(G) Expression of key pluripotency genes in 2C-like cells (2C), the rest of cells g
blastocyst stage (blast) of the embryo.
CeCells were harvested by trypsinization (0.05% trypsin/EDTA, GIBCO) for
10 min, at which point they reached 70%–80% confluence for single-cell
capture.
The three media are as follows:
(1) Serum-containing media: Knockout DMEM (GIBCO), 1X penicillin-
streptomycin-glutamine (GIBCO), 1X non-essential amino acids
(GIBCO), 100U/ml recombinant human leukemia inhibitory factor (Milli-
pore), 15% fetal bovine serum (HyClone), 0.1mM b-mercaptoethanol
(Sigma).ulated and downregulated genes in 2C-like cells.
ated in 2C-like cells (2C) in comparison to remaining cells grown in 2i media (2i).
rown in 2i media (2i), cells from the two-cell stage (2cell), and cells from the
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Figure 7. Validation of Putative Members of the Pluripotency Network
(A) Network showing known interactions of core pluripotency factors with the novel candidate genes. Data obtained from ChIP-seq and ChIP-ChIP experiments
from ESCAPE database.
(B) Schematic showing experimental design. Catalytically inactive Cas9 and gRNA bind to the promoter of the targeted gene, occluding it and competing for
binding with transcription factors and polymerases.
(C) Expression level of repressed genes in samples and control. Targets with significant repression are in blue.
(D) Barplot of gene expression levels of significantly differentially expressed genes in Ptma- and Zfp640-repressed samples (DESeq, multiple hypotheses testing
adjusted p < 0.05).
(E) Barplots showing the logarithm of p values for differential expression from DESeq of pluripotency (left) and differentiation (right) genes in the Ptma knockdown
samples. For genes that are downregulated, the numbers are negative, and they are positive for upregulated genes. The red line indicates a p threshold of 0.05.
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(2) Standard 2i media: N2B27 basal media (NDiff 227, StemCells),
100 U/ml recombinant human LIF (Millipore), 1 mM PD0325901 (Stem-
gent), 3 mM CHIR99021 (Stemgent).
(3) Alternative 2i media: N2B27 basal media (NDiff 227, StemCells),
100 U/ml recombinant human LIF (Millipore), 1 mMCGP77675 (Sigma),
3 mM CHIR99021 (Stemgent).
cDNA Library Preparation from Single Cells using the Fluidigm C1
For each culture condition, 4,000 cells were loaded on to a 10–17 mm Fluidigm
C1Single-Cell Auto Prep IFC, and cell capture was performed according to the
manufacturer’s instructions. The capture efficiency was inspected using a mi-
croscope to remove samples from the analysis with more than one cell
captured. Upon capture, reverse transcription and cDNA preamplification
were performed in the 10–17 mm Fluidigm C1 Single-Cell Auto Prep IFC using
the SMARTer PCR cDNA Synthesis Kit (Clontech) and the Advantage 2 PCR
Kit (Ramsko¨ld et al., 2012). cDNA was harvested and diluted to a range of
0.1–0.3 ng/ml and Nextera libraries were prepared using the Nextera XT DNA
Sample Preparation Kit and the Nextera Index Kit (Illumina) following the
instructions in the Fluidigm manual ‘‘Using the C1TM Single-Cell Auto Prep
System to Generate mRNA from Single Cells and Libraries for Sequencing.’’
Libraries from one chip were pooled, and paired-end 100 bp sequencing
was performed on four lanes of an Illumina HiSeq2000.
Bulk RNA-Sequencing
Bulk RNA-sequencing libraries were prepared and sequenced using the
Wellcome Trust Sanger Institute sample preparation pipeline with Illumina’s
TruSeq RNA Sample Preparation v2 Kit. RNA was extracted from 1–2 million
cells using the QIAGEN RNA Purification Kit on a QiaCube robot. The quality
of the RNA sample was checked using gel electrophoresis. For library
preparation, poly-A RNA was purified from total RNA using oligo-dT magnetic
pull-down. Subsequently, mRNA was fragmented using metal-ion catalyzed
hydrolysis. The cDNA was synthesized using random hexamer priming, and
end repair was performed to obtain blunt ends. A-tailing was done to enable
subsequent ligation of Illumina paired-end sequencing adapters, and samples
were multiplexed at this stage. The resulting library was amplified using 10 cy-
cles of PCR, substituting the Kapa Hifi polymerase for the polymerase in the
Illumina TruSeq Kit. Samples were diluted to 4nM, and 100 bp paired-end
sequencing was carried out on an Illumina HiSeq2000. Sequencing Quality
Control was performed by the Sanger sequencing facility.
Mapping Reads
Paired-end reads were mapped simultaneously to theMus musculus genome
(Ensembl version 38.73) using GSNAP (version gmap-2014-05-15_v2) using
default parameters. Subsequently we counted reads for each gene with
htseq-count and normalized them with size factors calculated from DESeq
as reported previously (Brennecke et al., 2013). We also applied location
and scale adjustments to the normalized read counts to remove technical vari-
ation among multiple batches (Supplemental Experimental Procedures).
Quality Control of Cells
To exclude poor quality cells from the downstream analysis, we removed cells
according to the following criteria: (1) empty capture sites or capture sites with
multiple cells or debris, as defined by visual inspection of the chip; (2) cells that
had fewer than 500,000 reads mapped to exons; and (3) cells that had over
10% reads mapped to mitochondrial genes (refer to Supplemental Experi-
mental Procedures for details).
Candidate Gene Expression Repression with CRISPR
45 guide RNAs targeting promoter regions of 7 candidate genes (Ptma, Set,
Zfp640, Zfp710, Kat6b, Dpy30, and Etv5) were cloned into gRNA-mCherry
plasmid (for a list of sequences, refer to Table S3). GFP-Oct4 reporter strain
ESCs (Silva et al., 2008) were transfected with (1) Cas9 repressor-BFP,
(2) transposase, and (3) a cocktail of gRNA plasmids (Gao et al., 2014)
targeting the gene of interest in a 1:1 ratio using Lipofectamine2000 (Life
Technologies). Subsequently, cells were cultured in medium containing 15%
serum and LIF for 4 days before 10,000 mCherry and BFP-positive cells
were sorted for each sample. RNA was extracted using QIAGEN RNeasy
Mini Kit. The SmartSeq2 protocol was used for reverse transcription andCeamplification of cDNA (Picelli et al., 2014). Sequencing libraries were prepared
using Nextera XT Kit according to the manufacturer’s guidelines, barcoded
with Nextera XT Dual Index Kit, and sequenced on an Illumina HiSeq2500 in
rapid mode.
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